Equillium, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Equillium, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for May 28, 2026, to vote on key proposals including a reverse stock split, an increase in authorized shares, director elections, and auditor ratification.
NASDAQ
DEFR14A: Equillium Seeks Stockholder Approval for Reverse Stock Split and Equity Incentive Plan Amendment
Equillium, Inc. is asking stockholders to approve a reverse stock split and an amendment to its equity incentive plan at the upcoming annual meeting.
NASDAQ
Equillium, Inc. will hold its annual stockholders meeting on May 21, 2025, featuring proposals including the election of directors, a potential reverse stock split, ratification of KPMG as the auditor, and an amendment to the equity incentive plan.
NASDAQ
Equillium, Inc. is asking stockholders to vote on key proposals at its upcoming annual meeting, including a reverse stock split, election of directors, and an amendment to the company's equity incentive plan.
NASDAQ
Equillium, Inc. will hold its annual stockholders meeting on May 22, 2024, to vote on director elections, a potential reverse stock split, auditor ratification, executive compensation, and the frequency of executive compensation votes.
NASDAQ
Equillium, Inc. is holding its 2024 annual meeting of stockholders on May 22, 2024, to vote on key proposals including a reverse stock split and the election of directors.